Overexpression and characterization of a bacterial α-N-acetylgalactosaminidase
-
摘要: 为了建立新型-N-乙酰半乳糖胺酶的筛选、检测方法,实验中提取脑膜金黄杆菌的基因组DNA,以此为模板PCR扩增出-N-乙酰半乳糖胺酶(A4).将A4克隆至pET-24a载体,转化Bl21表达菌株进行蛋白表达.使用亲和层析方法纯化His-A4酶,选择显色底物验证酶活性.同时,改进了传统的ELISA方法,直接将红细胞膜包被于ELISA检测平板中,以红细胞膜表面抗原作为直接底物,用ELISA方法检测酶活性.此研究建立了新型ELISA实验方法,以此方法验证了A4酶的活性,证明了此酶能够有效降低红细胞表面抗原抗体反应,且具有浓度和时间依赖性.
-
关键词:
- α-N-乙酰半乳糖胺酶 /
- 重组蛋白 /
- 蛋白纯化 /
- ELISA方法
Abstract: The coding sequence of alpha-N-acetylgalactosaminidase (A4) was amplified from genomic DNA of Chryseobacterium meningosepticum and subcloned into pET24a, which was then transformed into BL21(DE3) for overexpression of His-A4. The overexpressed His-A4 enzyme was purified by using affinity chromatography and its activity was comparable to that previously reported by using a conventional method with an artificial substrate. To better measure the activity of -N-acetylgalactosaminidase in real application, we established a novel method in which we directly used the surface antigen of red blood cell as substrate and applied ELISA to the detection of un-cleaved antigen. The activity of His-A4 was evaluated in the new ELISA method and was demonstrated to be able to decrease the blood cell surface antigen-antibody reaction in concentration- and time-dependent manner.-
Key words:
- α-N-acetylgalactosaminidase /
- recombination protein /
- protein purification /
- ELISA method
-
[1] [1] LANDSTEINER K. Agglutination phenomena of normal human blood[J]. Wiener Klinische Wochenschrift, 2001, 113(20-21): 768-769.[2] WATKINS W M. Biochemistry and genetics of the ABO, Lewis, and P blood group systems[J]. Advances in Human Genetics, 1980(10): 1-136, 379-385.[3] 章扬培,季守平,杨军.血型转变[J].中国实验血液学杂志,1998, 6(2): 91-97.[4] LIU Q P, SULZENBACHER G, YUAN H, et al. Bacterial glycosidases for the production of universal red blood cells[J]. Nature Biotechnology, 2007, 25(4): 454-464.[5] BAEHR R V. Biotechnology of blood[J]. Biotechnology, 1991, 19: 1-463.[6] GOLDSTEIN J, SIVIGLIA G, HURST R, et al. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals[J]. Science, 1982, 215(4529): 168-170.[7] KRUSKALL M S, AUBUCHON J P, ANTHONY K Y, et al. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O[J]. Transfusion, 2000, 40(11): 1290-1298.[8] ZHU A, GOLDSTEIN J. Cloning and functional expression of a cDNA encoding coffee bean alpha-galactosidase[J]. Gene, 1994, 140(2): 227-231.[9] OLSSON M L, CLAUSEN H. Modifying the red cell surface: towards an ABO-universal blood supply[J]. British Journal of Haematology, 2008, 140(1): 3-12.[10] DANIELS G, WITHERS S G. Towards universal red blood cells[J]. Nature Biotechnology, 2007, 25(4): 427-428.[11] LENNY L L, GOLDSTEIN J. The production of group O cells[J]. Biotechnology, 1991, 19: 75-100.[12] LAVECCHIO J A, DUNNE A D, EDGE A S. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies[J]. Transplantation, 1995, 60(8): 841-847.[13] 杨军,宫锋,季守平.B→O血型转变工具酶α-半乳糖苷酶cDNA克隆及表达[J]. 中国生物化学与分子生物学报,2000, 16(4): 438-442.[14] STEMMER W P. Rapid evolution of a protein in vitro by DNA shuffling[J]. Nature, 1994, 370(6488): 389-391.
点击查看大图
计量
- 文章访问数: 2282
- HTML全文浏览量: 18
- PDF下载量: 2232
- 被引次数: 0